Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Trimethylamine N-oxide (TMAO) Serum Levels on Index of Microcirculatory Resistance (IMR) in Patients Diagnosed With ST-Elevation Myocardial Infarction (STEMI)

NCT05406297 is registered in ClinicalTrials.gov with Lithuanian University of Health Sciences as lead sponsor.

NCT NCT05406297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05406297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Trimethylamine N-oxide (TMAO) Serum Levels on Index of Microcirculatory Resistance (IMR) in Patients Diagnosed With ST-Elevation Myocardial Infarction (STEMI)
Lead sponsor
Lithuanian University of Health Sciences
Phase
Observational
Overall status
Completed
Start date
January 12, 2021
Completion date
August 1, 2022
Enrollment
400 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microvascular coronary artery disease, stemi - st elevation myocardial infarction